Bionanotechnology in Cancer Diagnosis and Therapy 1st Edition
Original price was: $178.15.$29.97Current price is: $29.97.
This is a digital product. Review the product description for file formats and included materials. After successful payment, follow the access or download instructions sent to your checkout email.
The current price is shown on this page. Review the title, edition or course year and package contents before purchase. Your final total is displayed at checkout.
For product questions or help accessing an order, email [email protected]. Include your order number when available.
Use the payment methods displayed at checkout. Available options can vary by device and location. Credit and debit card payments are handled through Stripe.
Description
Bionanotechnology in Cancer Diagnosis and Therapy — 1st Edition
This first-edition research reference looks at nanotechnology applications at the interface of materials science, cancer detection and drug delivery. It explores how engineered nanoscale systems are studied for imaging, diagnostic sensing and targeted therapy.
Clinical and Scientific Coverage
- The design and characterization of nanoparticles for biomedical research.
- Nanomaterial interfaces with cells and biological tissues.
- Experimental cancer biomarkers and nanoscale detection strategies.
- Nanoparticle-mediated diagnostic imaging approaches.
- Targeted drug carriers and controlled-release research.
- Biosafety, biodistribution and translational research challenges.
How to Use This Reference
The field includes laboratory-stage systems with different evidence levels. Readers should evaluate the mechanistic basis of each technology and the difficulties of reproducibility, toxicity assessment and clinical validation before drawing conclusions about real-world use.
Intended Readers
Oncology researchers, nanotechnology specialists, biomedical engineers, pharmaceutical scientists and advanced students.
eBook & Access Details
Format: English-language PDF eBook. This listing supplies the PDF reference. It does not include investigational compounds, nanomaterials, imaging hardware, laboratory equipment or clinical therapeutic services.